These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 22054762)

  • 1. Biologic therapies: what and when?
    Johnston SL
    J Clin Pathol; 2007 Jan; 60(1):8-17. PubMed ID: 17213345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. To Combine or Not to Combine: Do We Need Concomitant Immunomodulators When Using Non-TNF-Targeting Biologics?
    Singh S; Hou JK
    Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2743-2745. PubMed ID: 36804992
    [No Abstract]   [Full Text] [Related]  

  • 3. The Risk of Systemic Diseases in Those with Psoriasis and Psoriatic Arthritis: From Mechanisms to Clinic.
    Woo YR; Park CJ; Kang H; Kim JE
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Rise of Non-Tuberculosis Mycobacterial Lung Disease.
    Ratnatunga CN; Lutzky VP; Kupz A; Doolan DL; Reid DW; Field M; Bell SC; Thomson RM; Miles JJ
    Front Immunol; 2020; 11():303. PubMed ID: 32194556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events.
    Subedi S; Gong Y; Chen Y; Shi Y
    Drug Des Devel Ther; 2019; 13():2491-2502. PubMed ID: 31413544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of serious infection in patients with rheumatoid arthritis-associated interstitial lung disease.
    Zamora-Legoff JA; Krause ML; Crowson CS; Ryu JH; Matteson EL
    Clin Rheumatol; 2016 Oct; 35(10):2585-9. PubMed ID: 27448151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The specialist physician's approach to rheumatoid arthritis in South Africa.
    Bester FC; Bosch FJ; van Rensburg BJ
    Korean J Intern Med; 2016 Mar; 31(2):219-36. PubMed ID: 26932399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rheumatoid arthritis is associated with higher ninety-day hospital readmission rates compared to osteoarthritis after hip or knee arthroplasty: a cohort study.
    Singh JA; Inacio MC; Namba RS; Paxton EW
    Arthritis Care Res (Hoboken); 2015 May; 67(5):718-24. PubMed ID: 25302697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in serious infections in rheumatoid arthritis.
    Ni Mhuircheartaigh OM; Matteson EL; Green AB; Crowson CS
    J Rheumatol; 2013 May; 40(5):611-6. PubMed ID: 23547208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary and peritoneal tuberculosis associated with tumor necrosis factor-alpha inhibitor use: a case report and review of the literature.
    Tipirneni N; Siegel MO
    Case Rep Pulmonol; 2012; 2012():598634. PubMed ID: 23304607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety of systemic treatments that can be used for geriatric psoriasis patients: a review.
    Wong JW; Koo JY
    Dermatol Res Pract; 2012; 2012():367475. PubMed ID: 22685455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic therapies in the treatment of psoriasis: a comprehensive evidence-based basic science and clinical review and a practical guide to tuberculosis monitoring.
    Sivamani RK; Goodarzi H; Garcia MS; Raychaudhuri SP; Wehrli LN; Ono Y; Maverakis E
    Clin Rev Allergy Immunol; 2013 Apr; 44(2):121-40. PubMed ID: 22311162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infections during treatment with biological agents and possible treatment in clinical practice.
    Atzeni F; Benucci M; Sarzi-Puttini P
    Expert Rev Clin Immunol; 2013 Mar; 9(3):193-5. PubMed ID: 23445193
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biopharmaceuticals in the treatment of rheumatoid arthritis].
    Baslund B; Bendtzen K
    Ugeskr Laeger; 2008 Jun; 170(24):2108-10. PubMed ID: 18572481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Infectious risk].
    Calabuig E; Salavert M
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():14-22. PubMed ID: 19080987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update upon efficacy and safety of TNF-α inhibitors.
    Murdaca G; Colombo BM; Cagnati P; Gulli R; Spanò F; Puppo F
    Expert Opin Drug Saf; 2012 Jan; 11(1):1-5. PubMed ID: 22010813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infectious complications of biologic agents.
    Martin-Mola E; Balsa A
    Rheum Dis Clin North Am; 2009 Feb; 35(1):183-99. PubMed ID: 19481004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologics and infections: lessons from tumor necrosis factor blocking agents.
    Wallis RS
    Infect Dis Clin North Am; 2011 Dec; 25(4):895-910. PubMed ID: 22054762
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.